BlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Sold by Corrado Advisors LLC

Corrado Advisors LLC reduced its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 25.2% in the 4th quarter, HoldingsChannel reports. The firm owned 11,617 shares of the company’s stock after selling 3,908 shares during the period. Corrado Advisors LLC’s holdings in BlackRock Health Sciences Term Trust were worth $170,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. raised its holdings in BlackRock Health Sciences Term Trust by 4.8% during the third quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock worth $250,000 after purchasing an additional 796 shares in the last quarter. Raymond James Financial Services Advisors Inc. raised its holdings in BlackRock Health Sciences Term Trust by 0.6% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 186,566 shares of the company’s stock worth $2,688,000 after purchasing an additional 1,041 shares in the last quarter. Janney Montgomery Scott LLC raised its holdings in BlackRock Health Sciences Term Trust by 4.0% during the third quarter. Janney Montgomery Scott LLC now owns 30,936 shares of the company’s stock worth $446,000 after purchasing an additional 1,199 shares in the last quarter. LPL Financial LLC raised its holdings in BlackRock Health Sciences Term Trust by 0.5% during the third quarter. LPL Financial LLC now owns 274,665 shares of the company’s stock worth $3,958,000 after purchasing an additional 1,231 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its holdings in BlackRock Health Sciences Term Trust by 22.4% during the third quarter. PNC Financial Services Group Inc. now owns 25,955 shares of the company’s stock worth $374,000 after purchasing an additional 4,745 shares in the last quarter.

BlackRock Health Sciences Term Trust Trading Up 1.3 %

NYSE BMEZ traded up 0.19 during trading hours on Tuesday, hitting 14.77. 173,500 shares of the stock were exchanged, compared to its average volume of 329,938. BlackRock Health Sciences Term Trust has a 12-month low of 12.93 and a 12-month high of 16.59. The stock has a 50-day moving average of 15.91 and a 200 day moving average of 14.94.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Monday, April 15th will be issued a $0.09 dividend. The ex-dividend date of this dividend is Friday, April 12th. This represents a $1.08 dividend on an annualized basis and a yield of 7.31%.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. acquired 113,312 shares of the company’s stock in a transaction dated Wednesday, January 24th. The stock was acquired at an average cost of 15.13 per share, with a total value of 1,714,410.56. Following the purchase, the insider now directly owns 17,495,017 shares in the company, valued at approximately 264,699,607.21. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Over the last three months, insiders purchased 2,055,802 shares of company stock valued at $32,347,047.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.